SeaStar Medical Holding Corporation Warrant (ICUCW)
$0.0154▼ −6.10%
Close Sep 25, 2026 · split-adjusted
Sep 25, 2026$0.02▼ 49.01% in range
Sep 29, 2025Low $0.01 · High $0.04Sep 25, 2026
What changed · written from our data
As of Sep 28, 2026
SeaStar Medical Holding Corporation Warrant closed at $0.02 on Sep 25, down 6.10%, 64.8% below its highest close since Oct 31. Volume of 1.1K shares was 0.06× its 20-day average (below normal).
Split-adjusted performance: -11.0% over one month, -45.0% over six months.
In the quarter ended Jun 30, 2026, revenue was $615K, up 82.0% from a year earlier, with a net margin of -606.5%.
Short interest was 6.7K shares at the Sep 15 settlement, down 24.2% from the prior report (1.0 days to cover).
No recent articles focused on SeaStar Medical Holding Corporation Warrant.
Quick answers
What does SeaStar Medical Holding Corporation Warrant do?
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
What is ICUCW's market cap?
$258.54K, based on the Sep 25 close of $0.02.
What sector is ICUCW in?
Healthcare, in the Surgical Instruments industry.
About SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology